GoldenGolden
PACT Pharma

PACT Pharma

PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.

The technology in development at PACT Pharma aims to reprogram immune systems to target and eradicate the cancer. PACT Pharma is engineering synthetic tumor-infiltrating lymphocytes (synthetic TILs), tailored for each patient's cancer with efficient turnaround in manufacturing from tumor biopsy to re-infusion of autologous synthetic TILs back into the patient.

PACT Pharma raised $95 million in Series B financing. Alphabet Inc.'s venture arm GV led the round, with participation from Invus Group, Canaan Partners, Casdin Capital, Wu Capital and other undisclosed investors.

Timeline

March 5, 2021
PACT Pharma announces planned retirement of CEO Alex Franzusoff.

January 11, 2020
PACT Pharma raises a $75,000,000 series C round from Vida Ventures.
May 25, 2018
PACT Pharma raises a $95,000,000 series B round from Canaan Partners, GV, Invus, UpHonest Capital and Wei Guo.
December 20, 2016
PACT Pharma raises a $30,000,000 series A round from GV.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
PACT Pharma Series B round, May 25, 2018
95,000,000
May 25, 2018
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
PACT Pharma
March 5, 2021
www.prnewswire.com:443
/PRNewswire/ -- PACT Pharma, Inc., a clinical-stage company pioneering individualized, non-viral precision genome engineered, tumor-specific T cell therapies...
PACT Pharma
January 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- PACT Pharma, Inc., a clinical-stage company developing transformational personalized neoTCR-T cell therapies for the eradication of solid...
Cellares Corporation
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Cellares Corporation, une société qui s'efforce de révolutionner la fabrication de thérapies cellulaires, a annoncé que PACT Pharma, Inc. une...
Cellares Corporation
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Die Cellares Corporation, ein Biotech-Unternehmen, das sich auf Revolutionierung der Herstellung von Zelltherapien konzentriert, hat bekannt...
Cellares Corporation
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Cellares Corporation, una compañía centrada en revolucionar la fabricación de terapia celular, anunció que PACT Pharma, Inc., una compañía de...
Cellares Corporation
January 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Cellares Corporation, a company focused on revolutionizing cell therapy manufacturing, announced that PACT Pharma, Inc., a clinical-stage...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.